Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 970 across all filing types
Latest filing 2023-10-23 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
董事会审计委员会工作细则（2023年10月）
Governance Information Classification · 95% confidence The document is titled as the "Audit Committee Work Rules" of Yantai Zhenghai Biotechnology Co., Ltd. It details the composition, responsibilities, meeting rules, and operational procedures of the company's audit committee. The content focuses on governance and oversight related to auditing and internal controls, rather than presenting financial statements or audit opinions themselves. The document is a governance-related internal regulation rather than an audit report or annual report. It does not contain financial data or audit results but sets out the framework for audit committee operations. Therefore, it fits best under Governance Information (CGR), which covers reports detailing internal rules, board structure, and governance practices. The document length is 3552 characters, which is consistent with a detailed governance document rather than a brief announcement or a full financial report. Confidence is high due to the clear focus on audit committee governance and procedural rules.
2023-10-23 Chinese
关于2023年第三季度报告披露的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (457 characters) indicating that the company's 2023 third quarter report has been approved and will be disclosed on a regulatory website. It does not contain the actual financial data or the full report itself, but rather a notice to investors to check the full report elsewhere. According to the 'MENU VS MEAL' rule, such a brief notice about report disclosure is classified as a Report Publication Announcement (RPA).
2023-10-23 Chinese
公司章程（2023年10月）
Governance Information Classification · 100% confidence The document is titled "公司章程" which translates to "Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, and other governance matters. It references Chinese company law and securities regulations, and includes sections on shareholder meetings, board of directors, management, and financial accounting systems. The document is a comprehensive governance framework for the company rather than a financial report or announcement. It is not an Annual Report, Interim Report, Earnings Release, nor a voting result announcement. It is not a proxy statement or remuneration report. It is a governance document detailing internal rules and structure. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full governance document, not just an announcement or summary.
2023-10-23 Chinese
关于续聘2023年度审计机构的公告
Regulatory Filings Classification · 95% confidence The document is titled as an announcement regarding the reappointment of the audit firm for the year 2023. It details the background, qualifications, and independence of the audit firm, the approval process by the board and audit committee, and the upcoming shareholder meeting to approve the appointment. The document does not contain any actual audit report, financial statements, or audit results. It is a formal announcement about the selection and continuation of the audit firm rather than the audit report itself. The document length is 3450 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, according to the classification rules, this document fits best under Audit Report / Information (AR) as it relates to audit matters but is not the full annual report or audit report itself. However, since it is an announcement of the audit firm appointment and not the audit report or audit results, it is more appropriate to classify it as Regulatory Filings (RNS) because it is a regulatory announcement about audit firm reappointment without substantive audit data or report content.
2023-10-23 Chinese
独立董事关于相关事项的事前认可意见
Audit Report / Information Classification · 90% confidence The document is a statement of prior approval by independent directors regarding the company's plan to reappoint the audit firm for the 2023 fiscal year. It references regulatory rules related to stock exchange listing and corporate governance but does not contain any financial data or audit results itself. The document is short (695 characters) and serves as an official opinion or endorsement rather than a full audit report or annual report. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or certification. Confidence is high given the clear focus on audit firm reappointment and independent directors' opinion. FY 2023
2023-10-23 Chinese
独立董事工作制度（2023年10月）
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System' and contains detailed rules and regulations governing the roles, responsibilities, nomination, election, rights, and obligations of independent directors within the company. It references relevant laws and regulatory frameworks such as the Company Law, Securities Law, and CSRC regulations. The content is a governance framework document rather than a report, announcement, or financial statement. It does not contain financial data, audit results, voting results, or any other reportable event. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-10-23 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.